Network Supply Planner
Job title:Network Supply Planner
Location: Warsaw, Poland
Hybrid Model: 3 days per week from office
Clinical Supply Chain is transforming and as part of that transformation we are building our approach to Capacity Planning. Thisclinicalplanning rolewill be a key part of building that new future. The role holder willlead the weeklySupply & OperationsExecution(S&OE)cycle andplay a key role in the Clinical Supply & Operations Planning(CS&OP)monthlyreview cycleacross AstraZeneca Global Clinical Supply Chain.
The NetworkSupplyPlanningrolewill ownthecrossclinical studyexternalsupplyplan, overthetacticalplanning horizon, ensuring this is constrained to known asset capacity, flexibility and whererelevantthe contractual agreements. As part of their planning responsibility, they will ensure that relevant supply constraints and events aremodelled.
This role will drive the S&OE process byfacilitatingthe relevant meeting and reviews anddevelopthe inputs intoCS&OPprocess where asset capacity is discussed for the whole clinical portfolio.
Network Supply Planning will be the gate keeper of the operational supply plan and the liaison between the external supplier /internalassetandinternalCM&Sstudy/projectfacingrolesensuringthataconstrained executable supply plan ismaintained.
The Network Supply Planner is accountable foroperatingthe S&OE and CS&OP processesfor anassigned clinical supply portfolio(e.g. Oral Solid Dose, Parenteral).
This includes:
End-to-end operation of theweekly S&OE cyclefor the portfolio, ensuring:
A constrained, executable supply plan is maintained
Near-term supply risks, events, and deviations areidentifiedand managed
Clear escalation of issues outside agreed tolerances
End-to-end operation of themonthly CS&OP cyclefor the portfolio, including:
Consolidation and governance of demand inputs
Application of demand scenarios for capacity testing
Complete portfolio-level Rough Cut Capacity Planning (RCCP) to createa capacity constrained, achievableNetworkSupplyPlan
Lead Supply Capability review meetings asa key step withinCS&OP cycle
Portfolio-level capacity risk assessment across internal assets and external suppliers
Preparation of decision-grade outputs for executive review
Acting as thesingle orchestration pointbetween:
Programme demand owners (CM&S / LCS)
Planners and CSPLs
Procurement and asset owners
Ensuring consistent application of:
Agreed timing and granularity rules
Capacity risk logic and RAG definitions
Decision, action, and follow-up discipline
The roleruns the planning governancefor the assigned portfolio.
It doesnotown forecast accuracy, recruitment assumptions, or detailed execution scheduling beyond S&OE scope.
Date Posted
18-lut-2026Closing Date
04-mar-2026AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorisation and employment eligibility verification requirements.
Gå med i vårt talangnätverk
Bli först med att få jobbuppdateringar och nyheter från AstraZeneca
Registrera